B7C-32725-71181
4 vaccinations
5 coded responses
52 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Registered in v-safe
-
2021-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-05
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-06-18
Survey response — 3 months, dose 2MedDRA: Irritable bowel syndrome, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: I've been diagnosed with a case of IBS-D. · Healthcare visit (other): Just a visit to my drs officeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-25
Call successfulParticipant prefers to complete VAERS report online
- 2021-09-17
-
2021-10-19
Dose 3 — Pfizer-BioNTech
- 2021-10-19
-
2021-10-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-10-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-10-25
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
-
2022-01-18
Survey response — 3 months, dose 3MedDRA: Malaise, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: I got sick and tested positive for Covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-20
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
-
2022-10-01
Survey response — day 14, dose 4MedDRA: Eye disorder, Pre-existing disease, Sneezing — Feeling: GoodFree text: I've been sneezing a lot and my eyes have been bothering me. It's probably just allergy related.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-15
-
2022-10-22
Survey response — day 35, dose 4MedDRA: Condition aggravated, Pre-existing disease, Rash — Feeling: FairFree text: A mild rash on the inside of both of my elbows. Also I'm experiencing a flare-up of my stomach and intestinal issues despite taking medicine for it.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
-
2022-12-17
Survey response — 3 months, dose 4MedDRA: Blood glucose increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: My blood sugar became elevated and I now require an additional medication despite watching what I eat, taking my other meds and exercise as tolerated.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — 3 months, dose 2
Symptoms: I've been diagnosed with a case of IBS-D.
Healthcare visit (other): Just a visit to my drs office
Release 10 — 3 months, dose 3
Symptoms: I got sick and tested positive for Covid.
Release 12 — day 14, dose 4
Symptoms: I've been sneezing a lot and my eyes have been bothering me. It's probably just allergy related.
Release 12 — day 35, dose 4
Symptoms: A mild rash on the inside of both of my elbows. Also I'm experiencing a flare-up of my stomach and intestinal issues despite taking medicine for it.
Release 12 — 3 months, dose 4
Symptoms: My blood sugar became elevated and I now require an additional medication despite watching what I eat, taking my other meds and exercise as tolerated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Irritable bowel syndrome | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release